Ilmer, M., Mazurek, N., Gilcrease, M. Z., Byrd, J. C., Woodward, W. A., Buchholz, T. A., . . . Bresalier, R. S. (2016). Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells. Breast Cancer Res.
Chicago Style CitationIlmer, Matthias, et al. "Low Expression of Galectin-3 Is Associated With Poor Survival in Node-positive Breast Cancers and Mesenchymal Phenotype in Breast Cancer Stem Cells." Breast Cancer Res 2016.
Cita MLAIlmer, Matthias, et al. "Low Expression of Galectin-3 Is Associated With Poor Survival in Node-positive Breast Cancers and Mesenchymal Phenotype in Breast Cancer Stem Cells." Breast Cancer Res 2016.
Atenció: Aquestes cites poden no estar 100% correctes.